Tag: Pentadecapeptide (gastric BPC fragment)

  • BPC-157

    Pentadecapeptide (gastric BPC fragment)

    A 15-amino-acid sequence derived from a gastric protective protein, broadly studied in tendon, ligament, vascular, and gut repair models.

    Abstract

    BPC-157, formally pentadecapeptide BPC 157 (Body Protection Compound 157), is a 15-residue partial sequence isolated from a larger gastric protective protein found in human gastric juice. The sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (CAS 137525-51-0; molecular formula C62H98N16O22; molecular weight 1419.55) was originally characterized in the 1990s by the Sikiric group at the University of Zagreb, who have authored the majority of the published preclinical record. Reported activities span tendon and ligament healing in transection models, vascular reorganization through nitric oxide synthase modulation and VEGF receptor 2 engagement, gastrointestinal mucosal protection, dopaminergic system modulation, and GH receptor crosstalk. Routes studied include intraperitoneal, intramuscular, subcutaneous, oral, and topical administration in rodent models; oral bioavailability is unusual for a peptide of this length and is attributed to the parent compound’s evolutionary role in the gut. Human pharmacokinetic data are sparse; one published Phase 1 single-ascending-dose study has been reported. BPC-157 is not approved by any regulatory authority for human or veterinary use. The literature base is dominated by a single research group, which is the principal limitation on the strength of the evidence; independent replications of the most-cited findings are limited but growing. This monograph reviews the chemistry, mechanism, pharmacokinetics and analytical identity of the compound, with a curated reference list.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.